Apoquel Tablets & Chewables
أبوكيل أقراص وأقراص قابلة للمضغ
Apoquel (oclacitinib tablet and chewable tablet) is a targeted Janus kinase (JAK-1) inhibitor indicated for the control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. Provides fast itch relief within 4 hours, comparable to steroids, without steroid-associated side effects.
Dosage Form
Tablet
Product Type
Pharmaceutical
Manufacturer
Package
Bottles of 20, 100, and 250 tablets or chewable tablets (3.6 mg, 5.4 mg, and 16 mg)
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Dog | 0.4 to 0.6 mg oclacitinib/kg body weight | Oral (PO) | Twice daily for up to 14 days, then once daily for maintenance |
Withdrawal Periods
No withdrawal information available.
Indications
-
Control of pruritus associated with allergic dermatitis in dogs at least 12 months of age.
-
Control of atopic dermatitis in dogs at least 12 months of age.
Contraindications
-
Do not use in dogs less than 12 months of age.
-
Do not use in dogs with serious infections.
-
Do not use in breeding dogs, pregnant, or lactating bitches.
Precautions
-
Apoquel modulates the immune system and may increase susceptibility to infections, including demodicosis and neoplasia.
-
Monitor dogs receiving long-term treatment with complete blood counts and serum chemistry periodically.
Side Effects
-
Most common side effects include vomiting, diarrhea, anorexia, lethargy, and localized skin infections.
Images
Documents
-
Download
Apoquel Tablets & Chewables Prescribing Information
Leaflet
Active Ingredients
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
No data available
Information has not been added yet.
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.